BofA analyst Alec Stranahan lowered the firm’s price target on BioXcel Therapeutics (BTAI) to $1 from $4 and keeps an Underperform rating on ...

BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $3.57 per share versus the Zacks Consensus Estimate of a loss of $4.36. This compares to loss of $12.16 per share a year ago. These ...

March 21, 2025 /PRNewswire/ -- "AI works 120 million times faster than the human brain," according to Dr. Neilank Jha ... aimed at attracting top talent in interdisciplinary studies. Xcell Biosciences ...

Apollo Health, a leading provider of clinically proven innovative health solutions for cognition, has partnered with Trifecta Nutrition, the nation's largest science-backed meal delivery service ...

Nurix Therapeutics (NRIX) announced that the U.S. Food and Drug Administration, FDA, has granted Orphan Drug Designation, ODD, to bexobrutideg, ...

HEM Pharma announced on the 12th that it has signed a memorandum of understanding (MOU) with Xcell Therapeutics for research and commercialization collaboration on microbiome-based bio-materials.

AMARILLO, Texas (KFDA) - Xcel Energy is preparing for high wind speeds on Friday which will increase the wildfire risk across the area. Xcel says customers are encouraged to plan for potential ...

Viking Therapeutics' stock declined by 37% following a downgrade to "hold" in December, anticipating competitive pressures from Novo Nordisk's CagriSema Phase 3 results. The company's GIP/GLP-1 ...

Knight Therapeutics Inc. GUD-T has signed a deal ... Mr. Goodman suffered a damaging brain injury in a bicycle accident in 2011 and nearly died, a life-changing event that led to the Paladin ...

My job, like many of yours, demands more from my brain than it is biologically capable of. The philosophical argument that phones, the internet, and AI tools are extensions of our minds Why humans ...

X, the popular social media app owned by billionaire Elon Musk, appeared to be malfunctioning Monday morning. Formerly known as Twitter, the rebranded website is no stranger to the occasional ...